Adapting LFI for Melioidosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-21

Study Completion Date

2019-01-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Towards the goal of reducing melioidosis, this study will help clinicians in Sarawak to diagnose and understand the causes and risk factors for melioidosis. The data will help the clinicians to provide faster test results and better clinical care. The investigator's laboratory efforts will supplement available diagnostics by adding a new, easier-to-use test involving lateral flow immunoassay to rapidly detect Burkholderia pseudomallei, a bacterium causing melioidosis. The study aims to study up to 400 patients with melioidosis-like symptoms who are admitted to Kapit Hospital, Sarawak, Malaysia. No participants will be enrolled from other sites. The study will also examine the demographic, behavioral and occupational risk factors associated with hospital admissions to understand any existing associations between these variables and melioidosis prevalence.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Lung Microbiome in Sarcoidosis

NCT02520323

Sarcoidosis

COMPLETED

Innovative Reagents for Improving Rapid Diagnosis of Mycobacterial Infections

NCT03808636

Tuberculosis (TB)

UNKNOWN

Rapid Identification of Mycobacteria in Acid-fast Bacilli Smear-positive Respiratory Specimens

NCT00999076

Atypical Mycobacteria Mycobacterium Infections

TERMINATED

Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers

NCT05203068

Tuberculosis

COMPLETED NA

Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts

NCT02098226

Infection

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Melioidosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with melioidosis-like symptoms admitted to Kapit Hosp

Lateral flow immunoassay

Intervention Type DEVICE

Biospecimens of patients with melioidosis-like symptoms will be tested with lateral flow immunoassay to detect Burkholderia pseudomallei, bacterium causing melioidosis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lateral flow immunoassay

Biospecimens of patients with melioidosis-like symptoms will be tested with lateral flow immunoassay to detect Burkholderia pseudomallei, bacterium causing melioidosis

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admitted to Kapit Hospital
* Fever more than 3 days and one or more of the following:

* Enlarged cervical, inguinal or axillary lymph nodes (greater than 3 cm in diameter), painless adenopathy or lymphadenitis or lymph node abscesses
* One or both sides glands involvement such as tender swelling over medial aspect of the lower eyelid of the lacrimal glands; submandibular glands, parotic glands
* Bedside scan with splenic or liver hypoechoic lesion (less than 2cm in diameter)
* Pneumonia not responding to 48 hours of first line antibiotics
* One or more joint pain with swelling
* Purplish vesicle or bullae mainly over the lower limbs, may resulting in ulcer after rupture
* Deep seated abscess or brain abscess or genitourinary abscess or osteomyelitis
* Severe sepsis patient with or without shock and/or with multiorgan involvement

Exclusion Criteria

* Have a clear alternative diagnosis other than melioidosis by a trained health care professional at the Kapit Hospital
* Have already been treated for melioidosis (e.g. received antibiotics before the start of the study)
* Are younger than 6 months of age

Minimum Eligible Age

6 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No